SSA
TMCI icon

Schonfeld Strategic Advisors’s Treace Medical Concepts TMCI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-62,674
Closed -$154K – 2670
2025
Q4 		$154K Sell
62,674
-373
-0.6% -$1.62K ﹤0.01% 1759
2025
Q3 		$423K Sell
63,047
-239,156
-79% -$1.56M ﹤0.01% 1730
2025
Q2 		$1.78M Sell
302,203
-84,300
-22% -$549K 0.01% 1044
2025
Q1 		$3.24M Buy
+386,503
New +$3.47M 0.02% 710
2024
Q1 		– Sell
-12,930
Closed -$165K – 2408
2023
Q4 		$165K Buy
+12,930
New +$131K ﹤0.01% 1564
2023
Q2 		– Sell
-21,300
Closed -$537K – 2493
2023
Q1 		$537K Buy
+21,300
New +$500K 0.01% 1148

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's TMCI Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 62,674 shares — an estimated $154K sold.

Schonfeld Strategic Advisors first reported a position in TMCI in Q1 2023 and held it in 6 quarters. The position peaked at $3.24M in Q1 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 62,674 Treace Medical Concepts shares in Q1 2026, an estimated $154K.
  • Schonfeld Strategic Advisors first reported a position in Treace Medical Concepts in Q1 2023 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's Treace Medical Concepts position peaked at $3.24M in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.